our partners harnessing AIDD for lead discovery

SLC Bio combines the power of AI computational chemistry drug discovery, with the know-how in context specific cell-based assays, to create novel therapies targeting Solute Carrier Transporters in oncology, expanding treatment options for patients into the “undruggable.” Our first focus is in acute myeloid leukemia, a blood cancer with high unmet need affecting an aging population.